Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Clear Cell Renal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05155033
What this trial is testing

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

Who this might be right for
Metastatic MelanomaAdvanced Locoregional MelanomaMetastatic Renal Cell Carcinoma+1 more
National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)Study completedNCT02917772
What this trial is testing

Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellClear-cell Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 200
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Looking for participantsNCT07128680
What this trial is testing

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+3 more
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00126503
What this trial is testing

Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Chromophobe Renal Cell CarcinomaClear Cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more
National Cancer Institute (NCI) 73
Testing effectiveness (Phase 2)Looking for participantsNCT05361720
What this trial is testing

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
Vanderbilt-Ingram Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Testing effectiveness (Phase 2)Looking for participantsNCT07551349
What this trial is testing

Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Beijing Biotech 36
Testing effectiveness (Phase 2)Study completedNCT00193258
What this trial is testing

Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
SCRI Development Innovations, LLC 94
Testing effectiveness (Phase 2)Study completedNCT02915783
What this trial is testing

A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease

Who this might be right for
Non Clear Cell Renal Cell Carcinoma (nccRCC)
Eisai Inc. 41
Early research (Phase 1)Study completedNCT00656734
What this trial is testing

Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.

Who this might be right for
Kidney Cancer
Bristol-Myers Squibb 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07218692
What this trial is testing

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+6 more
City of Hope Medical Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Looking for participantsNCT05433142
What this trial is testing

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Xencor, Inc. 307
Testing effectiveness (Phase 2)Study completedNCT03945773
What this trial is testing

Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors

Who this might be right for
Locally Advanced or Metastatic Renal Cell Carcinoma
Ipsen 127
Testing effectiveness (Phase 2)Ended earlyNCT01793636
What this trial is testing

A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Carcinoma
Queen Mary University of London 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT03634540
What this trial is testing

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Who this might be right for
Renal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma (ccRCC)Kidney Cancer+6 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 118
Testing effectiveness (Phase 2)Ended earlyNCT02771626
What this trial is testing

Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Calithera Biosciences, Inc 118
Early research (Phase 1)Ended earlyNCT05121948
What this trial is testing

HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)

Who this might be right for
Squamous Cell Carcinoma of Head and NeckColo-rectal CancerNon Small Cell Lung Cancer+3 more
HiberCell, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT00392821
What this trial is testing

Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
SCRI Development Innovations, LLC 78
Next Page